Trials / Completed
CompletedNCT03793023
Observational Study to Evaluate the Efficacy and Safety of Teneligliptin
Observational Study to Evaluate the Efficacy and Safety of Teneligliptin When Switched From Other DPP-4 Inhibitors in Type 2 DM With Inadequate Glycemic Control
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,983 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- —
Summary
This study is designed as a prospective, observational, multi-centre study to evaluate the efficacy and safety of Teneligliptin when switched from other DPP-4 inhibitors in type 2 DM with inadequate glycemic control
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teneligliptin 20mg |
Timeline
- Start date
- 2016-01-05
- Primary completion
- 2019-09-23
- Completion
- 2019-09-23
- First posted
- 2019-01-04
- Last updated
- 2025-01-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03793023. Inclusion in this directory is not an endorsement.